Trials Scheduled for Triple Negative Breast Cancer Vaccine @ Mayo Clinic
Exciting news for women who have been diagnosed with Triple Negative Breast Cancer. Researchers at the Mayo Clinic in Jacksonville, Florida are working on a vaccine to prevent this particularly aggressive type of breast cancer. The vaccine is showing great promise.
Triple Negative Breast Cancer is a highly aggressive type of breast cancer. It lacks the three main target proteins that most breast cancers have – Estrogen Receptors, Progesterone Receptors, and HER2 (human epidermal growth factor). The latter breast cancers are treated with hormonal therapies with drugs such as TAMOXIFEN and ANASTROZLE.
Researchers state Triple Negative Breast Cancer is most commonly found in younger women, African-American women, and those more commonly diagnosed with BRCA positive breast cancer genes.
Science has advanced rapidly in last few years with major advancements. Researchers are beginning to understand how our immune system and genetic makeup effect each other. As a result, science is learning how to produce an effective treatment so that our immune system will attack cancer cells within our bodies.
The Triple Negative Breast Cancer Vaccine begins testing this year at Mayo Clinic. Dr. Edith Perez (Mayo Clinic) hopes this Vaccine is a “Game Changer” for future treatments for breast cancer and is very excited and optimistic about the possibilities to treat breast cancers with vaccines in the future.
For more information about TRIPLE NEGATIVE BREAST CANCER visit the TRIPLE NEGATIVE BREAST CANCER FOUNDATION.
Please watch the video below for news on the Triple Negative Breast Cancer Vaccine.